FDA Fines Red Cross USD 4.6M Over Unsafe Blood Practices
Capital of the The Food and Drug Administration has ticketted the Red Cross an extra USD 4.6 000 000 for the statistical distribution of “inapplicable blood wares,” bringing penalisations against the organisation to more than USD 19 000 000 in recent old age.
The FDA published a missive Wednesday telling that it reexamined 113 recalls of rakehell products by the Red Cross from April 2003 to April 2006.